Fidelity National Financial Form 4: 100,000-share grant at $0

Q: What did FNF's CEO receive in this Form 4 filing (FNF)?

A grant of 100,000 shares of restricted common stock at $0 on November 10, 2025 .

Q: What is the vesting schedule for the 100,000 restricted shares at FNF?

They vest in three equal annual installments beginning November 10, 2026 , subject to performance criteria.

Q: How many FNF shares did the CEO hold directly after the reported transaction?

577,001.6534 shares held directly .

Q: How many FNF shares are held indirectly by the CEO?

14,585.324 shares held indirectly through the Michael J. Nolan Trust .

Q: What transaction code is shown for the FNF CEO's award?

Transaction code A , indicating an acquisition of securities.

Q: Is the FNF CEO a director or officer according to the filing?

The reporting person is an Officer , specifically the Chief Executive Officer .

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Fidelity National Financial (FNF) reported an insider equity award. On November 10, 2025, the Chief Executive Officer acquired 100,000 shares of common stock at $0 via a restricted stock grant. These shares vest in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement.

After the grant, the reporting person held 577,001.6534 shares directly and 14,585.324 shares indirectly through the Michael J. Nolan Trust.

Insider Trade Summary

Net Buyer: 100,000 shares

Net Buy 2 txns

Insider Nolan Michael Joseph

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	100,000	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 577,001.6534 shares (Direct); Common Stock — 14,585.324 shares (Indirect, Michael J. Nolan Trust)

Footnotes (1)

F1. Grant of restricted common stock vesting in three equal annual installments beginning November 10, 2026, subject to the achievement of performance criteria specified in the reporting person's award agreement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/13/2025 - 04:36 PM

FAQ

What did FNF's CEO receive in this Form 4 filing (FNF)?

A grant of 100,000 shares of restricted common stock at $0 on November 10, 2025.

What is the vesting schedule for the 100,000 restricted shares at FNF?

They vest in three equal annual installments beginning November 10, 2026, subject to performance criteria.

How many FNF shares did the CEO hold directly after the reported transaction?

577,001.6534 shares held directly.

How many FNF shares are held indirectly by the CEO?

14,585.324 shares held indirectly through the Michael J. Nolan Trust.

What transaction code is shown for the FNF CEO's award?

Transaction code A, indicating an acquisition of securities.

Is the FNF CEO a director or officer according to the filing?

The reporting person is an Officer, specifically the Chief Executive Officer.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nolan Michael Joseph

(Last)

(First)

(Middle)

601 RIVERSIDE AVENUE

(Street)

JACKSONVILLE

32204

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Fidelity National Financial, Inc. [ FNF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/10/2025		A		100,000⁽¹⁾	A	$0	577,001.6534	D
Common Stock								14,585.324	I	Michael J. Nolan Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of restricted common stock vesting in three equal annual installments beginning November 10, 2026, subject to the achievement of performance criteria specified in the reporting person's award agreement.

	/s/ Colleen E. Haley, as attorney-in-fact	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR